# Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial

> **NCT07731542** · NA · RECRUITING · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 192 (estimated)

## Conditions studied

- Functioanl Dyspepsia

## Interventions

- **DRUG:** Vonoprazan plus Itopride combination
- **DRUG:** Vonoprazan

## Key facts

- **NCT ID:** NCT07731542
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-10
- **Primary completion:** 2027-01-10
- **Final completion:** 2027-02-10
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2026-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07731542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07731542, "Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07731542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*